Our results show that BiP promotes FKBP9 protein stabilization and patients with both high expression of BiP and FKBP9 show a worse prognosis, indicating that the BiP–FKBP9 axis may play an important role in glioma patients. This evidence concerns the gene HSPA5 and central nervous system cancer.